Zoetis ZTS Other emerging markets — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's other emerging markets — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zoetis's other emerging markets — revenue?
- Zoetis (ZTS) reported other emerging markets — revenue of $291M in Q1 2026.
- How has Zoetis's other emerging markets — revenue changed year-over-year?
- Zoetis's other emerging markets — revenue increased by 22.3% year-over-year, from $238M to $291M.
- What is the long-term trend for Zoetis's other emerging markets — revenue?
- Over 4 years (2021 to 2025), Zoetis's other emerging markets — revenue has grown at a 3.8% compound annual growth rate (CAGR), from $778M to $903M.
- What does other emerging markets — revenue mean?
- This metric represents the total net sales generated from animal health products sold within geographic regions classified as emerging markets outside of the company's primary focus areas. It captures the demand for vaccines, parasiticides, and diagnostics in developing economies where livestock and companion animal health infrastructure is evolving. Growth in this segment reflects the company's ability to penetrate new markets and capitalize on rising pet ownership and protein demand in non-core international territories.